These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 9039201)
1. Butenafine 1% cream in the treatment of tinea cruris: a multicenter, vehicle-controlled, double-blind trial. Lesher JL; Babel DE; Stewart DM; Jones TM; Kaminester L; Goldman M; Weintraub JS J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S20-4. PubMed ID: 9039201 [TBL] [Abstract][Full Text] [Related]
2. One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial. Savin R; De Villez RL; Elewski B; Hong S; Jones T; Lowe N; Lucky A; Reyes B; Stewart D; Willis I J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S15-9. PubMed ID: 9039200 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of butenafine in superficial dermatophytoses (tinea pedis, tinea cruris, tinea corporis). Saple DG; Amar AK; Ravichandran G; Korde KM; Desai A J Indian Med Assoc; 2001 May; 99(5):274-5. PubMed ID: 11676116 [TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of topical 1% butenafine and 1% clotrimazole in tinea cruris and tinea corporis: a randomized, double-blind trial. Singal A; Pandhi D; Agrawal S; Das S J Dermatolog Treat; 2005; 16(5-6):331-5. PubMed ID: 16428155 [TBL] [Abstract][Full Text] [Related]
5. Butenafine: an update of its use in superficial mycoses. Gupta AK Skin Therapy Lett; 2002 Sep; 7(7):1-2, 5. PubMed ID: 12432425 [TBL] [Abstract][Full Text] [Related]
6. Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream. Tschen E; Elewski B; Gorsulowsky DC; Pariser DM J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S9-14. PubMed ID: 9039199 [TBL] [Abstract][Full Text] [Related]
7. A randomized trial to assess once-daily topical treatment of tinea corporis with butenafine, a new antifungal agent. Greer DL; Weiss J; Rodriguez DA; Hebert AA; Swinehart JM J Am Acad Dermatol; 1997 Aug; 37(2 Pt 1):231-5. PubMed ID: 9270509 [TBL] [Abstract][Full Text] [Related]
8. A double-blind, randomized, vehicle-controlled study evaluating the efficacy and safety of naftifine 2% cream in tinea cruris. Parish LC; Parish JL; Routh HB; Avakian E; Olayinka B; Pappert EJ; Plaum S; Fleischer AB; Hardas B J Drugs Dermatol; 2011 Oct; 10(10):1142-7. PubMed ID: 21968664 [TBL] [Abstract][Full Text] [Related]
9. A randomized, multicenter, double-blind, vehicle-controlled study evaluating the efficacy and safety of luliconazole cream 1% once daily for 7 days in patients aged ≥ 12 years with tinea cruris. Jones TM; Jarratt MT; Mendez-Moguel I; Paz N; Grekin SK; Cognata Smith C; Kaur M J Drugs Dermatol; 2014 Jan; 13(1):32-8. PubMed ID: 24385117 [TBL] [Abstract][Full Text] [Related]
10. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study. Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065 [TBL] [Abstract][Full Text] [Related]
11. Management of toenail onychomycosis with 2% butenafine and 20% urea cream: a placebo-controlled, double-blind study. Syed TA; Ahmadpour OA; Ahmad SA; Shamsi S J Dermatol; 1998 Oct; 25(10):648-52. PubMed ID: 9830263 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris. Lebwohl M; Elewski B; Eisen D; Savin RC Cutis; 2001 Mar; 67(3):261-6. PubMed ID: 11270304 [TBL] [Abstract][Full Text] [Related]
13. Treatment of tinea cruris with topical terbinafine. Greer DL; Jolly HW J Am Acad Dermatol; 1990 Oct; 23(4 Pt 2):800-4. PubMed ID: 2229527 [TBL] [Abstract][Full Text] [Related]
14. Butenafine hydrochloride: for the treatment of interdigital tinea pedis. Syed TA; Maibach HI Expert Opin Pharmacother; 2000 Mar; 1(3):467-73. PubMed ID: 11249531 [TBL] [Abstract][Full Text] [Related]
16. A comparative study to evaluate efficacy, safety and cost-effectiveness between Whitfield's ointment + oral fluconazole versus topical 1% butenafine in tinea infections of skin. Thaker SJ; Mehta DS; Shah HA; Dave JN; Kikani KM Indian J Pharmacol; 2013; 45(6):622-4. PubMed ID: 24347774 [TBL] [Abstract][Full Text] [Related]
17. Open clinical study of the efficacy and safety of terbinafine cream 1% in children with tinea corporis and tinea cruris. Bakos L; Brito AC; Castro LC; Gontijo B; Lowy G; Reis CM; Ribeiro AM; Souza FH; Villar Mdo L; Zaitz C Pediatr Infect Dis J; 1997 Jun; 16(6):545-8. PubMed ID: 9194102 [TBL] [Abstract][Full Text] [Related]
18. Butenafine and superficial mycoses: current status. Singal A Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):999-1005. PubMed ID: 18624686 [TBL] [Abstract][Full Text] [Related]
19. Butenafine hydrochloride (Mentax) cream for the treatment of hyperkeratotic type tinea pedis and its transfer into the horny layer, with or without concomitant application of 20% urea ointment (Keratinamin). Tanuma H; Doi M; Ohta Y; Abe M; Kume H; Mukai H; Katsuoka K Mycoses; 2001; 44(7-8):287-99. PubMed ID: 11714064 [TBL] [Abstract][Full Text] [Related]
20. Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental tinea pedis in guinea pigs. Arika T; Yokoo M; Maeda T; Amemiya K; Yamaguchi H Antimicrob Agents Chemother; 1990 Nov; 34(11):2254-5. PubMed ID: 2073117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]